Certified by Founder
Lodge
Mercy BioAnalytics, Inc.
start up
United States
- Natick, Massachusetts
- 04/04/2023
- Series A
- $41,000,000
Mercy BioAnalytics is on a mission to save lives and relieve suffering across the globe through the early detection of cancer. We have developed a novel liquid biopsy assay platform which interrogates tumor-derived extracellular vesicles, which are abundant in blood and carry information about their cell of origin, enabling detection of cancer even in at the earliest stages.
- Industry Biotechnology Research
- Website https://mercybio.com/
- LinkedIn https://www.linkedin.com/company/mercy-bioanalytics/
Related People
Dawn MattoonFounder
United States -
Natick, Massachusetts
Seasoned biotech leader with a passion for developing and commercializing impactful, innovative new products and developing high performing teams.
Voomi Supply | $10,000,000 | (Mar 10, 2026)
Axiomatic_AI | $18,000,000 | (Mar 10, 2026)
Advocacy | $3,500,000 | (Mar 10, 2026)
Crafting | $5,500,000 | (Mar 10, 2026)
Cylake | $45,000,000 | (Mar 10, 2026)
Augur | $15,000,000 | (Mar 10, 2026)
ANEUVO | $22,000,000 | (Mar 10, 2026)
DiligenceSquared (YC F25) | $5,000,000 | (Mar 10, 2026)
Mirai Robotics | $4,200,000 | (Mar 10, 2026)
Dify | $30,000,000 | (Mar 10, 2026)
Mega | $11,500,000 | (Mar 10, 2026)
Denki (YC F25) | $4,100,000 | (Mar 10, 2026)
KAST | $80,000,000 | (Mar 10, 2026)